SIGA Technologies Inc (SIGA) posted a Q3 net loss with no product sales, but secured a new five-year Canadian military contract worth up to $15 million while awaiting a delayed US government award.
Motley Fool Press Release.
Concludes 30-Year Tenure Leading Development of TPOXX®, the First FDA-Approved Antiviral for the Treatment of SmallpoxNEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies (NASDAQ: SIGA), a commercial stage pharmaceutical company, announced today that Dennis Hruby, Ph.D., Executive Vice President and Chief Scientific Officer, will retire effective today, concluding more than 30 years with the Company. Dr. Hruby joined SIGA in 1996 as a senior scientific advisor, became Vice President of
SIGA Technologies (NASDAQ:SIGA) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and
On August 6, SIGA Technologies (NASDAQ:SIGA) reported financial results for the three and six months ended June 30, and the numbers tell two very different stories depending on which quarter you compare them to. Revenue and profit both cratered from a year ago, yet the company still turned a profit, paid out a special dividend, […]
On Track to Deliver $13 Million of Oral TPOXX to an International Customer in Second QuarterExpect to Deliver $26 Million of IV TPOXX to the U.S....
Detailed price information for Siga Technologies Inc (SIGA-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.